70. 広範脊柱管狭窄症 Spinal stenosis Clinical trials / Disease details
臨床試験数 : 96 / 薬物数 : 203 - (DrugBank : 60) / 標的遺伝子数 : 66 - 標的パスウェイ数 : 89
Showing 1 to 10 of 96 diseases
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02459392 (ClinicalTrials.gov) | December 31, 2021 | 26/5/2015 | EuroPainClinics® Study II (Prospective Trial) | EuroPainClinics® Study II (Prospective Randomized Double Blinded Trial) | Lumbar Spinal Stenosis | Other: Epiduroscopy;Drug: Hyaluronic Acid;Drug: DepoMedrol | Europainclinics z.ú. | NULL | Completed | 18 Years | N/A | All | 300 | N/A | Czechia;Czech Republic |
2 | NCT05023733 (ClinicalTrials.gov) | October 1, 2021 | 16/8/2021 | Clinical and Radiographic Outcomes of TLIF w/3D Printed Cellular Implant | Clinical and Radiographic Outcomes of Transforaminal Lumbar Interbody Fusion (TLIF) With a Novel 3D Printed Cellular Titanium Implant Clinical and Radiographic Outcomes of Transforaminal Lumbar Interbody Fusion (TLIF) With a Novel 3D ... | Foraminal Stenosis;Degenerative Disc Disease;Lumbar Spondylolisthesis;Lumbar Spinal Stenosis | Device: CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Titanium® Device: CONDUIT™ Interbody Platform composed of the EIT (Emerging Implant Technologies) Cellular Tit ... | Farhan Karim | DePuy Synthes | Not yet recruiting | 35 Years | 80 Years | All | 150 | United States | |
3 | NCT04992572 (ClinicalTrials.gov) | October 2021 | 21/7/2021 | Study Comparing Local/ MAC Anesthesia in Lumbar Decompression | Randomized Study Comparing Local/ MAC Anesthesia to General for 1-3 Level Lumbar Decompressions | Lumbar Spinal Stenosis | Drug: Propofol Injection;Drug: Lidocaine Hydrochloride, Injectable | Stanford University | NULL | Not yet recruiting | 40 Years | 95 Years | All | 100 | Early Phase 1 | United States |
4 | NCT04066296 (ClinicalTrials.gov) | September 2021 | 3/7/2019 | Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine | A Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposomal Bupivicaine A Double Blinded Randomized Control Trial in Outcomes for Lumbar Decompressions With Use of Liposoma ... | Lumbar Spinal Stenosis | Drug: Liposomal bupivacaine | University of Colorado, Denver | NULL | Not yet recruiting | 18 Years | N/A | All | 100 | Phase 2 | NULL |
5 | NCT05029726 (ClinicalTrials.gov) | September 2021 | 14/8/2021 | Regional Anesthesia in Minimally Invasive Lumbar Spine Surgery | Randomized, Placebo-controlled Trial of Erector Spinae Plane Blocks (ESPB) for Perioperative Pain Management for Minimally Invasive (MIS) Lumbar Spine Surgery Randomized, Placebo-controlled Trial of Erector Spinae Plane Blocks (ESPB) for Perioperative Pain Ma ... | Lumbar Spinal Stenosis;Lumbar Disc Herniation;Lumbar Spondylolisthesis;Lumbar Spondylosis;Lumbar Radiculopathy;Lumbar Spine Instability;Synovial Cyst;Degenerative Disc Disease;Degenerative Spondylolisthesis;Degenerative Intervertebral Discs Lumbar Spinal Stenosis;Lumbar Disc Herniation;Lumbar Spondylolisthesis;Lumbar Spondylosis;Lumbar Rad ... | Drug: Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine;Drug: normal saline Drug: Bupivacaine-Epinephrine 0.25%-1:200,000 Injectable Solution plus clonidine;Drug: normal saline ... | John O'Toole | NULL | Not yet recruiting | 18 Years | 75 Years | All | 125 | Phase 4 | United States |
6 | NCT04537026 (ClinicalTrials.gov) | June 16, 2021 | 28/8/2020 | The SAFE Trial. Sterile Amniotic Fluid Filtrate Epidural Injection. | A Phase I/II Double-Blinded Randomized Prospective Study of Sterile Amniotic Fluid Filtrate Epidural Injection for the Treatment of Lumbosacral Radicular Pain Due to Spinal Stenosis: The SAFE Trial (Improving Safety and Outcomes in the Treatment of Pain and Disability Related to Spinal Stenosis). A Phase I/II Double-Blinded Randomized Prospective Study of Sterile Amniotic Fluid Filtrate Epidural ... | Lumbar Spinal Stenosis | Drug: Amniotic Fluid Allograft;Drug: Dexamethasone sodium phosphate | University of Utah | Cell Therapy & Regenerative Medicine;SKAGGs Foundation | Recruiting | 18 Years | N/A | All | 112 | Phase 1/Phase 2 | United States |
7 | ChiCTR2100046515 | 2021-06-01 | 2021-05-18 | To Evaluate the Clinical Efficacy of Zhuanyao Decoction in the Treatment of Degenerative Lumbar Spinal Stenosis Based on the Theory of 'Yanghua Qi' To Evaluate the Clinical Efficacy of Zhuanyao Decoction in the Treatment of Degenerative Lumbar Spin ... | To Evaluate the Clinical Efficacy of Zhuanyao Decoction in the Treatment of Degenerative Lumbar Spinal Stenosis Based on the Theory of 'Yanghua Qi' To Evaluate the Clinical Efficacy of Zhuanyao Decoction in the Treatment of Degenerative Lumbar Spin ... | Degenerative lumbar spinal stenosis | Treatment group:Zhuanyaotang Decoction granules + Mecobalamin tablets simulation agent+ Celecoxib capsules simulation agent;Control group:Methobalamin tablet + Celecoxib capsule + Zhuanyaotang Decoction granule simulation agent; Treatment group:Zhuanyaotang Decoction granules + Mecobalamintablets simulation agent+ Celecoxibcaps ... | Wang Jing Hospital, Chinese Academy of Traditional Chinese Medicine | NULL | Recruiting | 45 | 70 | Both | Treatment group:52;Control group:52; | N/A | China |
8 | NCT04483297 (ClinicalTrials.gov) | November 18, 2020 | 14/7/2020 | First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) | First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion Surgery First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative S ... | Degenerative Spondylolisthesis;Spinal Stenosis | Drug: AK1320 MS;Other: Control | Asahi Kasei Pharma Corporation | Emergent Clinical Consulting, LLC | Recruiting | 22 Years | 80 Years | All | 40 | Phase 1 | Canada |
9 | NCT04308122 (ClinicalTrials.gov) | October 1, 2020 | 6/3/2020 | Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical Fusion | A Randomized Trial of Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical Fusion A Randomized Trial of Cervical Orthosis Versus no Orthosis Following Multi-level Posterior Cervical ... | Posterior Cervical Spinal Surgery;Myelopathy Cervical;Radiculopathy, Cervical;Spinal Stenosis Cervical;Spondylosis, Cervical Posterior Cervical Spinal Surgery;Myelopathy Cervical;Radiculopathy, Cervical;Spinal StenosisCervica ... | Device: Cervical Orthosis (CO);Device: No Orthosis | Dr. Christopher Bailey | NULL | Recruiting | 18 Years | N/A | All | 40 | N/A | Canada |
10 | NCT04540068 (ClinicalTrials.gov) | October 2020 | 1/9/2020 | Prediction of TEI Success in Sciatica | Prediction Of Transforaminal Epidural Injection Success in Sciatica | Sciatica;Lumbar Disc Herniation;Lumbar Spinal Stenosis;Lumbar Radiculopathy | Drug: Transforaminal Epidural Injection | EJAVerheijen | Spaarne Gasthuis | Not yet recruiting | 18 Years | N/A | All | 538 | Netherlands |